ModelEdge

Relmada Therapeutics, Inc.
RLMD
Filing Type8-K
Filing Date12/14/2025
Updated12/15/25, 5:50 AM

Filing

8-K
Earnings Release

Exhibits

8-KChanges in Board, Management or Compensation
EX-10.1AMENDED AND RESTATED EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JANUARY 1, 2026, BETWEEN RELMADA THERAPEUTICS, INC. AND SERGIO TRAVERSA
EX-10.2AMENDED AND RESTATED EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JANUARY 1, 2026, BETWEEN RELMADA THERAPEUTICS, INC. AND PAUL KELLY
EX-10.3AMENDED AND RESTATED EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JANUARY 1, 2026, BETWEEN RELMADA THERAPEUTICS, INC. AND MAGED SHENOUDA
EX-10.4AMENDED AND RESTATED EMPLOYMENT AGREEMENT, EFFECTIVE AS OF JANUARY 1, 2025, BETWEEN RELMADA THERAPEUTICS, INC. AND CHARLES ENCE
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic